4 days ago

Netflix (NFLX) Stock Nears Earnings With $64–$77 Range in Focus

TLDR Netflix shares have fallen nearly 47% from their June 2025 peak, ahead of Tuesday’s earnings. Options markets suggest Netflix...

4 days ago

Intel (INTC) Stock Rebounds, but JPMorgan Keeps $85 Target

TLDR Intel stock gained about 4% in premarket trading after JPMorgan upgraded the chipmaker to Neutral. JPMorgan maintained its $8...

4 days ago

AMZN Stock Rises as Morgan Stanley Sees 40% Upside

TLDR Morgan Stanley raises its Amazon price target to $350, indicating 40% potential upside. AMZN stock gains around 2% after fall...

4 days ago

Strategy Inc (MSTR) Stock: Eyes Recovery as Buyback Program Hits $3B

TLDR MSTR rebounds 2.09% in premarket trading after Friday’s steep 9.56% decline. Strategy raises its preferred securities repurch...

4 days ago

Cleveland-Cliffs (CLF) Stock: Soars on Strong Q3 Profit and Revenue Growth

TLDR CLF stock rallies 12.39% to $13.65 in premarket trading after strong Q3 results. Third-quarter revenue hits $5.6 billion as n...

6 days ago

Amazon.com, Inc. (AMZN) Stock: Drops as Screenless Fitness Bracelets Gain Popula...

TLDR Amazon stock slipped 1.87% Friday, followed by a 0.47% after-hours decline. Screenless fitness bracelets offer tracking witho...

6 days ago

Bloom Energy Corporation (BE) Stock: Drops as Company Donates $10,000 to Texas P...

TLDR Bloom Energy (BE) stock slips 1.49% to $218.01 in Friday’s after-hours trade. Bloom Energy donates $10,000 to a nonprofit sup...

6 days ago

Robo.ai Inc. (AIIO) Stock: Plunges as Company Announces 1-for-25 Reverse Split

TLDR Robo.ai (AIIO) stock sank 10.80% Friday, then dropped another 6.49% after hours. Robo.ai proposes a 1-for-25 reverse share sp...

1 week ago

NVIDIA (NVDA) Stock: Slips as Company Expands Nemotron 3.5 AI Models

TLDR NVIDIA (NVDA) shares slip 0.06% to $217.09 amid new AI model announcements Nemotron 3.5 expansion targets better AI model eff...

1 week ago

ImmunityBio, Inc. (IBRX) Stock: Slides 7.25% Despite Major Breakthrough in Bladd...

TLDR ImmunityBio stock tumbles 7.25% to $9.27 despite promising ANKTIVA trial data. ANKTIVA delivers a 71% complete response rate...